Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 110
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

CLINICAL STUDY

The risk factors for cytomegalovirus reactivation following stem cell transplantation

Valadkhani Bahareh, Kargar Mona, Ashouri Asieh, Hadjibabaie Molouk, Gholami Kheirollah, Ghavamzadeh Ardeshir

Year : 2016| Volume: 5| Issue : 1 | Page no: 63-69

   This article has been cited by
 
1 Severe Hypogammaglobulinemia Associated with Active Lupus Nephritis Treatment Resulting in Cytomegalovirus Infection
Min Kyung Chung,Yeunmi Kang,Jisoo Lee
Journal of Rheumatic Diseases. 2019; 26(4): 273
[Pubmed]  [Google Scholar] [DOI]
2 Factors associated with cytomegalovirus infection in children undergoing allogeneic hematopoietic stem-cell transplantation
Tang-Her Jaing,Tsung-Yen Chang,Shih-Hsiang Chen,Yu-Chuan Wen,Ting-Jiuan Yu,Ching-Fen Lee,Chao-Ping Yang,Pei-Kwei Tsay
Medicine. 2019; 98(4): e14172
[Pubmed]  [Google Scholar] [DOI]
3 Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)
Amandine Fayard,Elisabeth Daguenet,Didier Blaise,Patrice Chevallier,Hélène Labussière,Ana Berceanu,Ibrahim Yakoub-Agha,Gérard Socié,Amandine Charbonnier,Felipe Suarez,Anne Huynh,Mélanie Mercier,Claude-Eric Bulabois,Bruno Lioure,Sylvain Chantepie,Yves Beguin,Jean-Henri Bourhis,Jean-Valère Malfuson,Laurence Clément,Régis Peffault de la Tour,Jérôme Cornillon
Bone Marrow Transplantation. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Cytomegalovirus infection in Systemic Lupus Erythematosus: report of four cases challenging the management of the disease, and literature review
G.D. Sebastiani,A. Iuliano,C. Canofari,M. Bracci
Lupus. 2019; 28(3): 432
[Pubmed]  [Google Scholar] [DOI]
5 Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease
Yoshiko Mizukawa,Kazuhisa Hirahara,Yoko Kano,Tetsuo Shiohara
Journal of the American Academy of Dermatology. 2019; 80(3): 670
[Pubmed]  [Google Scholar] [DOI]
6 Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Lauren Stern,Barbara Withers,Selmir Avdic,David Gottlieb,Allison Abendroth,Emily Blyth,Barry Slobedman
Frontiers in Microbiology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
7 The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review
Daanish Al Mana,Daanish Yassine,Daanish Younes,Daanish Al-Mohannadi,Daanish Al-Sadeq,Daanish Alhababi,Daanish Nasser,Daanish Nasrallah
Pathogens. 2019; 8(4): 213
[Pubmed]  [Google Scholar] [DOI]
8 Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
Cynthia X. Wang,Milan J. Anadkat,Amy C. Musiek
American Journal of Clinical Dermatology. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 New Developments in the Management of Cytomegalovirus Infection After Transplantation
Atibordee Meesing,Raymund R. Razonable
Drugs. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation
Brandon J. Webb,Rachel Harrington,Jason Schwartz,Jennifer Kammerer,James Spalding,Edward Lee,Bart Dodds,Stephanie Kaufusi,Bruce E. Goodman,Sean D. Firth,Greta Martin,Jeffrey Sorensen,Daanish Hoda
Transplant Infectious Disease. 2018; : e12961
[Pubmed]  [Google Scholar] [DOI]
11 Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem
N Berman,H M Belmont
Lupus. 2017; 26(4): 431
[Pubmed]  [Google Scholar] [DOI]
12 Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R. McCurdy,Christopher G. Kanakry,Hua-Ling Tsai,Yvette L. Kasamon,Margaret M. Showel,Javier Bolaños-Meade,Carol Ann Huff,Ivan Borrello,William H. Matsui,Robert A. Brodsky,Richard F. Ambinder,Maria P. Bettinotti,Ephraim J. Fuchs,Gary L. Rosner,Richard J. Jones,Leo Luznik
Biology of Blood and Marrow Transplantation. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article